Publications & press
oasicare joins global partnership with Maternity foundation
Oasicare joins global partnership with Maternity Foundation to strengthen care for women after childbirth
Copenhagen, 6 November 2025 — oasicare is proud to announce its participation in a new Danish-led cross-sector partnership focused on improving care for women affected by childbirth injuries worldwide.
Together with Maternity Foundation, GynZone: We Share Women’s Care, and Angella Invest, the partnership brings together expertise from women’s health innovation, clinical training, and global implementation.
The initiative — supported by ~1 million DKK raised through members of Angella Invest, GynZone and oasicare — will fund the development of a digital training module focused on management of birth injuries to be integrated into Maternity Foundation’s Safe Delivery App. The app already supports over 500,000 midwives and healthcare professionals globally.
Oasicare contributes funding, innovation, and strategic engagement in women’s health to help ensure that every woman receives high-quality care after childbirth — regardless of where she gives birth.
The project begins in November 2025, with a global launch planned for 2026.
SUH report
Report from Roskilde pilot testing released
In 2024, oasicare conducted our first pilot testing of our perineal-protection device in clinical practice at Sjællands Universitetshospital Roskilde GYN-OBS maternity ward. This seven-month collaboration with midwives and birth givers provided critical real-world insights that shaped our current device design and prepared us for the currently ongoing 100-woman study at Hvidovre and Roskilde Hospital.
Key findings from the trial:
Midwife-driven feedback for design works – Direct, continuous feedback from Roskilde midwives led to a device that fits into clinical workflows and showed to be safe for mother and baby.
Strong patient engagement – Birth givers showed high interest in innovations that improve quality of care, resulting in higher-than-expected participation.
Working together with midwives, for midwives has proven essential to creating a safe and usable device in the complex setting of birth – to ultimately improve women’s quality of care. We extend our thanks to the Roskilde midwives, especially Hanne Willer who led the testing, the participating birth givers, and hospital management for making this milestone possible.
Find the full report and insights from the pilot in the link